Dataset from A Randomized Double-Blind, Double-Dummy, Phase 3 Study to Evaluate the Efficacy and Safety of Oral TAK-438 20 mg Compared to Lansoprazole 30 mg Once- or Twice-Daily in the Treatment of Endoscopically Confirmed Duodenal Ulcer Subjects With or Without Helicobacter Pylori Infection
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00007238
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to demonstrate the non-inferior efficacy of TAK-438 versus
lansoprazole in the treatment of participants with duodenal ulcer.
创建时间：
2025-10-01
